Contact Tandem Diabetes stock loss lawyer Timothy L. Miles about a Tandem Diabetes class action lawsuit
EVERYTHING YOU NEED TO KNOW ABOUT THE TANDEM DIABETES CLASS ACTION LAWSUIT
The Tandem Diabetes class action lawsuit seeks to represent purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, inclusive (the “Class Period”). Captioned Lowe v. Tandem Diabetes Care, Inc., No. 23-cv-01657 (S.D. Cal.), the Tandem Diabetes class action lawsuit charges Tandem Diabetes and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered losses in Tandem Diabetes stock and wish to serve as lead plaintiff in the Tandem Diabetes class action, please contact Tandem Diabetes Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected]. Lead plaintiff motions for the Tandem Diabetes class action lawsuit must be filed with the court no later than November 7, 2023.
ALLEGATIONS IN THE TANDEM DIABETES CLASS ACTION LAWSUIT
Tandem Diabetes is a global medical technology company that develops, manufactures, and markets a variety of consumer technologies and software for at-home diabetes care.
The Tandem Diabetes class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Tandem Diabetes misled investors by creating the false impression that the impact of competitors’ products was minimal or less than expected; (ii) Tandem Diabetes’ forecasting processes failed to adequately account for the potential impact of the release of Omnipod 5, a competing product, and the impact of that product on Tandem Diabetes’ revenue; and (iii) Tandem Diabetes created the false impression that the factors which led to decreased sales guidance in August 2022 – competition, the COVID-19 pandemic, and inflation – had been adequately controlled for and were, in fact, improving.
The Tandem Diabetes class action lawsuit further alleges that on November 2, 2022, Tandem Diabetes updated its 2022 annual guidance to lower annual sales estimates from the range of $835 million to $845 million to an updated range of $800 million to $805 million. The Tandem Diabetes class action lawsuit alleges that on this news, the price of Tandem Diabetes stock fell.
THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE TANDEM DIABETES CLASS ACTION LAWSUIT
Serving as a Lead Plaintiff in the Tandem Diabetes class action lawsuit has several advantages and important benefits including:
Thus, there are numerous benefits to serving as lead plaintiff in a class action against Tandem Diabetes if you suffered losses in Tandem Diabetes stock.
CAN I BE LEAD PLAINTIFF IN THE TANDEM DIABETES CLASS ACTION LAWSUIT IF I AM LEAD PLAINTIFF IN ANOTHER CASE?
Yes, unless you have been a lead plaintiff in more than five securities class actions during any three-year period which is expressly prohibited by the securities laws. Otherwise, if you suffered losses in Tandem Diabetes stock, you may move to be appointed lead plaintiff in the Tandem Diabetes class action lawsuit.
HOW WAS THE CLASS PERIOD DETERMINED IN THE TANDEM DIABETES CLASS ACTION LAWSUIT?
In a securities fraud class action, the class period refers to a period of time in which it is alleged the price of the company’s stock was artificially inflated due to false and misleading statements made by company executives. The class period starts when the company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading. The class period ends when the truth is revealed to the investing public through a corrective disclosure.
In order to be a part of the class in the Tandem Diabetes class action lawsuit, you must have suffered losses in Tandem Diabetes stock by purchasing during the class period when it is alleged the price of the stock was artificially inflated to be included in the class action against Tandem Diabetes.
HOW MUCH CAN you GET OUT OF THE TANDEM DIABETES CLASS ACTION LAWSUIT
In a securities fraud class action lawsuit such as the Tandem Diabetes class action lawsuit, the plaintiff’s damages are typically calculated as out-of-pocket losses. These losses are expressed as the difference between the price at which the stock was sold and the price at which the stock would have been sold absent any artificial inflation caused by the defendant’s alleged misrepresentations or omissions which is why you suffered losses in Tandem Diabetes stock. Contact a Tandem Diabetes stock loss lawyer who can explain your losses in greater detail along with a Tandem Diabetes class action lawsuit.
WHEN CAN I EXPECT TO RECEIVE MY PAYMENT IF THE TANDEM DIABETES CLASS ACTION LAWSUIT SETTLES?
If there is a settlement in the Tandem Diabetes class action lawsuit., you should receive a court ordered Notice through the mail which will provide a date when the court will hold a final hearing to decide if it will approve the settlement. If your address changed, you may also find lawsuits through sites such as Consumer Action and ClassAction.org along with instructions on how to submit a claim. The Notice will instruct you what you need to do to file a claim. In some class action settlements, you are automatically submitted and need to do nothing further. However, in others, you may be required to submit more information to proceed such as documentation proving your purchase, such as a receipt or brokerage slip or other evidence that you bought or sold Tandem Diabetes stock during the class period and suffered losses in Tandem Diabetes stock.
The court will hold a final hearing in the Tandem Diabetes class action lawsuit on a date provided in the Notice to decide whether to finally approve the settlement. If the Court finally approves the settlement, and there are no objections or appeals, settlement payments will be mailed to all Participating Class Members within a few months. However, if there are objections or appeals, resolving them can take a significant amount of time, perhaps more than a year to resolve the Tandem Diabetes lawsuit.
IF THERE IS A SETTLEMENT IN THE TANDEM DIABETES CLASS ACTION LAWSUIT, AND you DO NOT THINK IT IS FAIR, WHAT ARE your OPTIONS AS A CLASS MEMBER?
If you suffered losses in Tandem Diabetes stock and are a member of the class, it does not cost anything to hire a Tandem Diabetes stock loss lawyer. Our firm litigates securities fraud cases on a contingent fee basis, so plaintiffs and the class do not pay attorneys’ fees or court costs unless there is a recovery, and the attorney fees and cost are awarded by the court as a percentage of the total recovery for the class. So, contact a Tandem Diabetes stock loss lawyer today if you suffered losses in Tandem Diabetes stock about a Tandem Diabetes class action lawsuit.
CONTACT A TANDEM DIABETES STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN TANDEM DIABETES STOCK ABOUT A TANDEM DIABETES CLASS ACTION LAWSUIT
If you suffered losses in Tandem Diabetes stock, contact Tandem Diabetes stock loss lawyer Timothy L. Miles today for a free case evaluation about a Tandem Diabetes class action lawsuit. Call today and see what a Tandem Diabetes stock loss lawyer can do for you if you suffered losses in Tandem Diabetes stock.
Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors,shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top 9National Trial Lawyers, National Trial Lawyers Association (2023), a superb ratedattorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime.
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846-6529
Email: [email protected]
HOURS OF OPERATION